Lenalidomide Combination Trumps Older Drugs for Multiple MyelomaLenalidomide Combination Trumps Older Drugs for Multiple Myeloma
Lenalidomide plus dexamethasone more effectively treats newly diagnosed multiple myeloma patients ineligible for stem-cell transplantation, regardless of age, than a triplet of older drugs, researchers report. Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Dexamethasone | Health | Hematology | Myeloma | Pathology | Revlimid | Stem Cell Therapy | Stem Cells | Transplants